2015
DOI: 10.1590/s1984-82502015000200016
|View full text |Cite
|
Sign up to set email alerts
|

Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: a comparison between two tablet formulations of cephalexin

Abstract: The aim of the present study was to assess the bioequivalence of two cephalexin tablet formulations available in the Brazilian market (product A as reference formulation and product B as test formulation). Dissolution efficiency (DE%) was calculated for both formulations to evaluate their in vitro biopharmaceutical features. The oral bioequivalence study was performed in twenty-four healthy volunteers in a crossover design. Single oral dose (tablet containing 500 mg of cephalexin) of each product was administe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0
3

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 20 publications
(33 reference statements)
0
2
0
3
Order By: Relevance
“…Cefalexina e amoxicilina, o primeiro e o segundo mais prescritos, são beta-latâmicos inibidores da parede celular bacteriana, sendo o primeiro pertencente ao grupo das cefalosporinas semissintéticas de primeira geração e o segundo ao grupo das penicilinas semissintéticas (17,18). A amoxicilina, geralmente, é prescrita em associação a um inibidor da beta-lactamase, como sulbactam ou ácido clavulânico (18).…”
Section: Resultsunclassified
See 1 more Smart Citation
“…Cefalexina e amoxicilina, o primeiro e o segundo mais prescritos, são beta-latâmicos inibidores da parede celular bacteriana, sendo o primeiro pertencente ao grupo das cefalosporinas semissintéticas de primeira geração e o segundo ao grupo das penicilinas semissintéticas (17,18). A amoxicilina, geralmente, é prescrita em associação a um inibidor da beta-lactamase, como sulbactam ou ácido clavulânico (18).…”
Section: Resultsunclassified
“…O quarto, azitromicina, é um macrolídeo inibidor da síntese de proteínas bacterianas, utilizado no tratamento das infecções bacterianas do trato respirató-rio, e também nas infecções da pele e dos tecidos moles (19,20). Todos os antimicrobianos citados apresentam amplo espectro de ação principalmente contra bactérias aeróbias (1,2,(17)(18)(19)(20).…”
Section: Resultsunclassified
“…It is obvious that using Q0.5 h as a release parameter involves comparison of single release points in order to evaluate the ability of the investigated formulations to release a fast initial dose of the loaded drug. On the other hand, the concept of RE% has some advantages over the single point parameter, the most important being that it can be theoretically related to in vivo data [65].…”
Section: Effect On In Vitro Release Studiesmentioning
confidence: 99%
“…This study used a concentration of 4 PPM, 8 PPM, 16 PPM, 20 PPM, and 24 PPM. The dissolved quercetin was then read for its absorbance using spectrophotometry with a wavelength of 435 nm [12]. After obtaining the absorbance of each concentration, the standard curve value was calculated.…”
Section: Tablet Dissolution Testmentioning
confidence: 99%